glp 1 alcohol addiction IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target GLP-1 Medications and Addiction —
Description
Preclinical studies also suggest that DPP-4 inhibitors help preserve -cell function, potentially slowing the progression of T 2 DM
Daily wellness support
This had no impact on the peer review process and the final decision
10.1210/en.2003-0364 [DOI] [PubMed] [Google Scholar] 88.Ahren B, Hughes TE
